These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27984168)

  • 1. The protective mechanism of docosahexaenoic acid in mouse model of Parkinson: The role of hemeoxygenase.
    Ozkan A; Parlak H; Tanriover G; Dilmac S; Ulker SN; Birsen I; Agar A
    Neurochem Int; 2016 Oct; ():. PubMed ID: 27984168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal nitric oxide synthase phosphorylation induced by docosahexaenoic acid protects dopaminergic neurons in an experimental model of Parkinson's disease.
    Parlak H; Ozkan A; Dilmac S; Tanriover G; Ozsoy O; Agar A
    Folia Histochem Cytobiol; 2018; 56(1):27-37. PubMed ID: 29577226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease.
    Hacioglu G; Seval-Celik Y; Tanriover G; Ozsoy O; Saka-Topcuoglu E; Balkan S; Agar A
    Folia Histochem Cytobiol; 2012 Jul; 50(2):228-38. PubMed ID: 22763967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.
    Ozsoy O; Seval-Celik Y; Hacioglu G; Yargicoglu P; Demir R; Agar A; Aslan M
    Neurochem Int; 2011 Oct; 59(5):664-70. PubMed ID: 21736911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of docosahexaenoic Acid on visual evoked potentials in a mouse model of Parkinson's disease: the role of cyclooxygenase-2 and nuclear factor kappa-B.
    Ozsoy O; Tanriover G; Derin N; Uysal N; Demir N; Gemici B; Kencebay C; Yargicoglu P; Agar A; Aslan M
    Neurotox Res; 2011 Oct; 20(3):250-62. PubMed ID: 21234736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroprotective effect of cinnamaldehyde in MPTP-induced mouse model of subacute Parkinson's disease].
    Wu SH; Shi YJ; An YF; Zhao DD; Li HB; Li GL
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(23):6485-6493. PubMed ID: 36604895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease.
    Tanriover G; Seval-Celik Y; Ozsoy O; Akkoyunlu G; Savcioglu F; Hacioglu G; Demir N; Agar A
    Folia Histochem Cytobiol; 2010 Sep; 48(3):434-41. PubMed ID: 21071351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rk1 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease via activating silence information regulator 3-mediated Nrf2/HO-1 signaling pathway.
    Ren Y; Ye D; Ding Y; Wei N
    Hum Exp Toxicol; 2023; 42():9603271231220610. PubMed ID: 38105596
    [No Abstract]   [Full Text] [Related]  

  • 10. Paeoniflorin protects 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mice by inhibiting oxidative stress and neuronal apoptosis through activating the Nrf2/HO-1 signaling pathway.
    Zhang J; Bai Q; Wen Q; Han L; Shi Y; Zhang X
    Neuroreport; 2023 Mar; 34(5):255-266. PubMed ID: 36881748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective Effect of β-Lapachone in MPTP-Induced Parkinson's Disease Mouse Model: Involvement of Astroglial p-AMPK/Nrf2/HO-1 Signaling Pathways.
    Park JS; Leem YH; Park JE; Kim DY; Kim HS
    Biomol Ther (Seoul); 2019 Mar; 27(2):178-184. PubMed ID: 30739428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential Heme Oxygenase-1 Activation in Striatal Astrocytes Antagonizes Dopaminergic Neuron Degeneration in MPTP-Intoxicated Mice.
    Xu X; Song N; Wang R; Jiang H; Xie J
    Mol Neurobiol; 2016 Oct; 53(8):5056-65. PubMed ID: 26385576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different susceptibility to the Parkinson's toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1.
    Innamorato NG; Jazwa A; Rojo AI; García C; Fernández-Ruiz J; Grochot-Przeczek A; Stachurska A; Jozkowicz A; Dulak J; Cuadrado A
    PLoS One; 2010 Jul; 5(7):e11838. PubMed ID: 20676377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRPV4 contributes to ER stress and inflammation: implications for Parkinson's disease.
    Liu N; Bai L; Lu Z; Gu R; Zhao D; Yan F; Bai J
    J Neuroinflammation; 2022 Jan; 19(1):26. PubMed ID: 35093118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-oxidative and anti-neuroinflammatory role of Necrostatin-1s and docosahexaenoic acid in RIP-1-mediated neurotoxicity in MPTP-induced Parkinson's disease model.
    Kartik S; Pal R; Chaudhary MJ; Tiwari PC; Nath R; Kumar M
    Fundam Clin Pharmacol; 2023 Aug; 37(4):794-806. PubMed ID: 36807936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Nrf2-dependent mechanism of b-Ecdysterone in attenuating the motor dysfunction in the MPTP/Pro-induced Parkinson's disease mice model.
    Rong H; Li X; Yu C; Wang W; Li L; Xu T; Ding Y; Su Y; Wang X
    Folia Neuropathol; 2024; 62(1):83-95. PubMed ID: 38174686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
    Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway.
    Jo MG; Ikram M; Jo MH; Yoo L; Chung KC; Nah SY; Hwang H; Rhim H; Kim MO
    Mol Neurobiol; 2019 Jan; 56(1):39-55. PubMed ID: 29675576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperbaric Oxygen Therapy Improves Parkinson's Disease by Promoting Mitochondrial Biogenesis via the SIRT-1/PGC-1α Pathway.
    Hsu HT; Yang YL; Chang WH; Fang WY; Huang SH; Chou SH; Lo YC
    Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease.
    Liang Y; Chen C; Xia B; Wu W; Tang J; Chen Q; Tang L; Yang H; Zhang Z; Lu Y; Yang Y; Zhao Y
    Biomed Res Int; 2019; 2019():4379639. PubMed ID: 30834264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.